Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Fertilization in Vitro | 62 | 2023 | 1284 | 6.960 |
Why?
|
Embryo Transfer | 39 | 2023 | 510 | 4.430 |
Why?
|
Preimplantation Diagnosis | 9 | 2023 | 151 | 3.720 |
Why?
|
Infertility | 16 | 2023 | 655 | 3.380 |
Why?
|
Oocytes | 26 | 2023 | 1187 | 3.170 |
Why?
|
Infertility, Female | 24 | 2020 | 787 | 3.130 |
Why?
|
Cryopreservation | 20 | 2023 | 670 | 3.060 |
Why?
|
Reproductive Techniques, Assisted | 16 | 2023 | 482 | 3.040 |
Why?
|
Public Opinion | 9 | 2019 | 477 | 2.820 |
Why?
|
Pregnancy Rate | 34 | 2023 | 643 | 2.610 |
Why?
|
Oocyte Retrieval | 13 | 2022 | 161 | 2.550 |
Why?
|
Ovulation Induction | 14 | 2023 | 274 | 2.510 |
Why?
|
Chorionic Gonadotropin | 10 | 2019 | 477 | 2.240 |
Why?
|
Live Birth | 12 | 2023 | 512 | 2.140 |
Why?
|
Aneuploidy | 10 | 2023 | 530 | 1.970 |
Why?
|
Fertility | 12 | 2023 | 781 | 1.920 |
Why?
|
Oocyte Donation | 4 | 2021 | 49 | 1.870 |
Why?
|
Abortion, Spontaneous | 12 | 2023 | 544 | 1.860 |
Why?
|
Sperm Injections, Intracytoplasmic | 9 | 2023 | 160 | 1.660 |
Why?
|
Pregnancy | 88 | 2023 | 29144 | 1.480 |
Why?
|
Ovary | 11 | 2020 | 981 | 1.440 |
Why?
|
Estradiol | 23 | 2014 | 2020 | 1.260 |
Why?
|
Pregnancy, Ectopic | 6 | 2017 | 141 | 1.250 |
Why?
|
Genetic Testing | 9 | 2023 | 3444 | 1.240 |
Why?
|
Reproductive Medicine | 3 | 2020 | 108 | 1.190 |
Why?
|
Embryo, Mammalian | 11 | 2022 | 1701 | 1.190 |
Why?
|
Leuprolide | 4 | 2023 | 321 | 1.190 |
Why?
|
Blastocyst | 9 | 2023 | 424 | 1.160 |
Why?
|
Ovarian Hyperstimulation Syndrome | 3 | 2020 | 53 | 1.090 |
Why?
|
Progesterone | 12 | 2018 | 776 | 1.050 |
Why?
|
Gonadotropins | 4 | 2020 | 241 | 1.050 |
Why?
|
Maternal Age | 8 | 2019 | 802 | 1.040 |
Why?
|
Follicle Stimulating Hormone, Human | 2 | 2020 | 25 | 1.020 |
Why?
|
Tissue Preservation | 2 | 2016 | 182 | 0.890 |
Why?
|
Pregnancy Outcome | 18 | 2021 | 2795 | 0.870 |
Why?
|
Single Embryo Transfer | 2 | 2019 | 29 | 0.840 |
Why?
|
Birth Rate | 4 | 2023 | 170 | 0.820 |
Why?
|
Paternal Age | 1 | 2021 | 84 | 0.780 |
Why?
|
Obesity | 12 | 2023 | 12745 | 0.770 |
Why?
|
Contraceptive Devices, Female | 2 | 2018 | 43 | 0.770 |
Why?
|
Embryo Implantation | 10 | 2023 | 272 | 0.770 |
Why?
|
Luteal Phase | 3 | 2018 | 147 | 0.750 |
Why?
|
Female | 162 | 2023 | 380194 | 0.740 |
Why?
|
Ovarian Follicle | 7 | 2022 | 247 | 0.740 |
Why?
|
Anti-Mullerian Hormone | 5 | 2021 | 402 | 0.710 |
Why?
|
Surrogate Mothers | 2 | 2018 | 17 | 0.700 |
Why?
|
Follicle Stimulating Hormone | 6 | 2012 | 744 | 0.690 |
Why?
|
Personal Autonomy | 2 | 2018 | 298 | 0.680 |
Why?
|
Health Knowledge, Attitudes, Practice | 4 | 2019 | 3923 | 0.670 |
Why?
|
Pregnancy, Multiple | 6 | 2023 | 217 | 0.650 |
Why?
|
Adult | 108 | 2023 | 214055 | 0.640 |
Why?
|
Uterine Hemorrhage | 4 | 2023 | 255 | 0.630 |
Why?
|
Directed Tissue Donation | 1 | 2017 | 19 | 0.600 |
Why?
|
Infant, Small for Gestational Age | 1 | 2020 | 440 | 0.600 |
Why?
|
Insemination, Artificial | 4 | 2011 | 98 | 0.590 |
Why?
|
Chorionic Gonadotropin, beta Subunit, Human | 1 | 2017 | 73 | 0.590 |
Why?
|
Intrauterine Devices, Medicated | 1 | 2017 | 28 | 0.580 |
Why?
|
Levonorgestrel | 1 | 2017 | 77 | 0.570 |
Why?
|
Compensation and Redress | 1 | 2017 | 71 | 0.570 |
Why?
|
Transsexualism | 1 | 2019 | 178 | 0.550 |
Why?
|
Polycystic Ovary Syndrome | 1 | 2020 | 370 | 0.550 |
Why?
|
Breast Neoplasms | 20 | 2022 | 20822 | 0.540 |
Why?
|
Endometrial Neoplasms | 2 | 2018 | 1353 | 0.530 |
Why?
|
Menstruation Disturbances | 1 | 2016 | 148 | 0.530 |
Why?
|
Humans | 166 | 2023 | 744343 | 0.530 |
Why?
|
Carcinoma, Endometrioid | 1 | 2018 | 271 | 0.510 |
Why?
|
Gastroplasty | 1 | 2016 | 142 | 0.510 |
Why?
|
Endocrinology | 2 | 2013 | 443 | 0.500 |
Why?
|
Premenopause | 6 | 2012 | 1033 | 0.490 |
Why?
|
Ideal Body Weight | 1 | 2014 | 27 | 0.480 |
Why?
|
Young Adult | 29 | 2023 | 56430 | 0.470 |
Why?
|
Antineoplastic Agents, Hormonal | 3 | 2011 | 1524 | 0.460 |
Why?
|
Insemination, Artificial, Homologous | 1 | 2013 | 18 | 0.460 |
Why?
|
Retrospective Studies | 45 | 2023 | 77449 | 0.450 |
Why?
|
Uterus | 5 | 2018 | 711 | 0.450 |
Why?
|
Hysterectomy | 3 | 2018 | 927 | 0.440 |
Why?
|
Posthumous Conception | 1 | 2012 | 11 | 0.440 |
Why?
|
Semen | 4 | 2023 | 316 | 0.440 |
Why?
|
Survivors | 6 | 2014 | 2291 | 0.440 |
Why?
|
Recombinant Proteins | 4 | 2020 | 6622 | 0.430 |
Why?
|
Estrogen Replacement Therapy | 7 | 1999 | 1203 | 0.420 |
Why?
|
Preconception Care | 3 | 2019 | 134 | 0.410 |
Why?
|
Ultrasonography, Prenatal | 5 | 2018 | 1695 | 0.400 |
Why?
|
Methotrexate | 2 | 2017 | 1727 | 0.380 |
Why?
|
Postmenopause | 8 | 2000 | 2461 | 0.380 |
Why?
|
Prolactin | 6 | 2020 | 669 | 0.370 |
Why?
|
Tissue Donors | 4 | 2021 | 2240 | 0.370 |
Why?
|
Bariatric Surgery | 2 | 2010 | 952 | 0.360 |
Why?
|
Neoplasms | 8 | 2023 | 21683 | 0.350 |
Why?
|
Multiple Birth Offspring | 1 | 2009 | 21 | 0.350 |
Why?
|
Adolescent | 28 | 2023 | 85781 | 0.330 |
Why?
|
Myometrium | 2 | 2004 | 181 | 0.330 |
Why?
|
Amenorrhea | 4 | 2021 | 485 | 0.320 |
Why?
|
Tamoxifen | 2 | 2011 | 981 | 0.310 |
Why?
|
Gastric Bypass | 1 | 2016 | 812 | 0.310 |
Why?
|
Primary Ovarian Insufficiency | 2 | 2023 | 115 | 0.310 |
Why?
|
Vaginal Creams, Foams, and Jellies | 3 | 2018 | 63 | 0.300 |
Why?
|
Patient Selection | 2 | 2019 | 4215 | 0.300 |
Why?
|
Body Mass Index | 11 | 2023 | 12720 | 0.300 |
Why?
|
Insurance Coverage | 1 | 2018 | 1901 | 0.300 |
Why?
|
Attitude | 1 | 2012 | 776 | 0.290 |
Why?
|
Obesity, Morbid | 1 | 2018 | 1213 | 0.290 |
Why?
|
Estrone | 3 | 1998 | 240 | 0.290 |
Why?
|
Receptors, LHRH | 1 | 2007 | 160 | 0.290 |
Why?
|
Embryo Culture Techniques | 3 | 2021 | 80 | 0.290 |
Why?
|
Alkylating Agents | 2 | 2023 | 139 | 0.280 |
Why?
|
Fertility Agents, Female | 5 | 2011 | 99 | 0.280 |
Why?
|
Antineoplastic Agents | 8 | 2023 | 13695 | 0.270 |
Why?
|
Hysteroscopy | 4 | 2023 | 102 | 0.270 |
Why?
|
Mammary Glands, Animal | 5 | 2009 | 276 | 0.270 |
Why?
|
Pregnancy Trimester, First | 3 | 2018 | 853 | 0.270 |
Why?
|
Spermatozoa | 3 | 2021 | 625 | 0.260 |
Why?
|
Potassium Chloride | 2 | 2004 | 237 | 0.260 |
Why?
|
Reproduction | 2 | 2012 | 668 | 0.260 |
Why?
|
Patient Acceptance of Health Care | 1 | 2019 | 3022 | 0.250 |
Why?
|
Ethanol | 3 | 1996 | 1342 | 0.250 |
Why?
|
Pregnancy, Tubal | 1 | 2004 | 16 | 0.250 |
Why?
|
Gonadotropin-Releasing Hormone | 2 | 2009 | 1205 | 0.240 |
Why?
|
Electrocoagulation | 1 | 2004 | 158 | 0.230 |
Why?
|
Linear Models | 4 | 2019 | 5952 | 0.230 |
Why?
|
Chorion | 2 | 2018 | 117 | 0.230 |
Why?
|
Trophoblasts | 1 | 2005 | 215 | 0.230 |
Why?
|
Age Factors | 11 | 2021 | 18370 | 0.230 |
Why?
|
Health Services Accessibility | 2 | 2018 | 5137 | 0.230 |
Why?
|
Ploidies | 2 | 2021 | 281 | 0.230 |
Why?
|
Healthcare Disparities | 1 | 2018 | 3158 | 0.220 |
Why?
|
Hematopoietic Stem Cell Transplantation | 2 | 2021 | 5442 | 0.220 |
Why?
|
Male | 42 | 2023 | 350118 | 0.220 |
Why?
|
Uterine Diseases | 1 | 2023 | 135 | 0.210 |
Why?
|
Menopause | 3 | 2008 | 1626 | 0.210 |
Why?
|
Oogenesis | 1 | 2022 | 131 | 0.210 |
Why?
|
Germ Cells | 2 | 2022 | 631 | 0.200 |
Why?
|
Reproductive Techniques | 1 | 2001 | 42 | 0.200 |
Why?
|
Alcohol Drinking | 5 | 2012 | 3966 | 0.200 |
Why?
|
Gamete Intrafallopian Transfer | 1 | 2001 | 27 | 0.200 |
Why?
|
Metacarpus | 1 | 2001 | 35 | 0.200 |
Why?
|
Insemination | 1 | 2021 | 19 | 0.200 |
Why?
|
Menstruation | 2 | 2017 | 302 | 0.200 |
Why?
|
Middle Aged | 33 | 2021 | 213383 | 0.200 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2017 | 3523 | 0.200 |
Why?
|
Cross-Sectional Studies | 8 | 2019 | 25043 | 0.190 |
Why?
|
Education, Medical | 1 | 2013 | 1721 | 0.190 |
Why?
|
Insurance | 1 | 2022 | 111 | 0.190 |
Why?
|
Sterilization Reversal | 1 | 2020 | 5 | 0.190 |
Why?
|
Nitrogen Mustard Compounds | 1 | 2020 | 45 | 0.190 |
Why?
|
Counseling | 2 | 2018 | 1523 | 0.180 |
Why?
|
Fertilization | 3 | 2010 | 196 | 0.180 |
Why?
|
Th2 Cells | 1 | 2005 | 1061 | 0.180 |
Why?
|
Treatment Outcome | 17 | 2022 | 63114 | 0.180 |
Why?
|
Zygote | 1 | 2000 | 116 | 0.180 |
Why?
|
Chromosome Segregation | 1 | 2001 | 235 | 0.180 |
Why?
|
Infant, Newborn | 9 | 2023 | 25625 | 0.180 |
Why?
|
Erectile Dysfunction | 1 | 2023 | 461 | 0.180 |
Why?
|
Administration, Intravaginal | 2 | 2018 | 150 | 0.180 |
Why?
|
Sterilization, Tubal | 1 | 2020 | 87 | 0.170 |
Why?
|
United States | 15 | 2022 | 69872 | 0.170 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2012 | 2020 | 0.170 |
Why?
|
Societies, Medical | 1 | 2011 | 3743 | 0.170 |
Why?
|
Progestins | 2 | 2018 | 306 | 0.170 |
Why?
|
Family Planning Services | 1 | 2022 | 263 | 0.170 |
Why?
|
Embryonic Development | 5 | 2017 | 711 | 0.170 |
Why?
|
Pregnancy Complications, Neoplastic | 2 | 2017 | 255 | 0.170 |
Why?
|
Ovarian Neoplasms | 2 | 2015 | 4838 | 0.160 |
Why?
|
Logistic Models | 5 | 2018 | 13408 | 0.160 |
Why?
|
Reproductive Rights | 1 | 2018 | 35 | 0.150 |
Why?
|
Odds Ratio | 5 | 2018 | 9849 | 0.150 |
Why?
|
Luteinizing Hormone | 1 | 2020 | 869 | 0.150 |
Why?
|
Gravidity | 1 | 2017 | 51 | 0.150 |
Why?
|
Intergenerational Relations | 1 | 2017 | 68 | 0.150 |
Why?
|
Estrogens | 6 | 2001 | 1566 | 0.150 |
Why?
|
Transforming Growth Factor beta | 1 | 2005 | 2007 | 0.150 |
Why?
|
Vitrification | 1 | 2017 | 56 | 0.150 |
Why?
|
Marital Status | 1 | 2019 | 437 | 0.150 |
Why?
|
Single-Blind Method | 2 | 2018 | 1590 | 0.150 |
Why?
|
Menotropins | 1 | 1996 | 45 | 0.150 |
Why?
|
Menstrual Cycle | 2 | 2011 | 551 | 0.140 |
Why?
|
Injections, Intramuscular | 3 | 2014 | 552 | 0.140 |
Why?
|
Hemoglobinuria, Paroxysmal | 1 | 2017 | 102 | 0.140 |
Why?
|
Cohort Studies | 13 | 2022 | 40561 | 0.140 |
Why?
|
Anastomosis, Surgical | 1 | 2020 | 987 | 0.140 |
Why?
|
Testosterone | 3 | 2020 | 2420 | 0.140 |
Why?
|
Biomimetics | 1 | 2017 | 172 | 0.140 |
Why?
|
Chemotherapy, Adjuvant | 2 | 2021 | 3479 | 0.140 |
Why?
|
Down-Regulation | 1 | 2023 | 3002 | 0.130 |
Why?
|
Pregnancy Complications, Hematologic | 1 | 2017 | 183 | 0.130 |
Why?
|
Bone Marrow Diseases | 1 | 2017 | 231 | 0.130 |
Why?
|
Anemia, Aplastic | 1 | 2017 | 226 | 0.130 |
Why?
|
Contraceptive Agents, Female | 1 | 2017 | 135 | 0.130 |
Why?
|
BRCA1 Protein | 2 | 2022 | 1149 | 0.130 |
Why?
|
Hematologic Neoplasms | 1 | 2007 | 1832 | 0.130 |
Why?
|
Biological Assay | 1 | 2018 | 652 | 0.130 |
Why?
|
Kidney Failure, Chronic | 2 | 1998 | 2538 | 0.130 |
Why?
|
Risk Factors | 15 | 2019 | 72290 | 0.130 |
Why?
|
Prenatal Care | 1 | 2022 | 1092 | 0.130 |
Why?
|
Cross-Over Studies | 6 | 2000 | 2029 | 0.120 |
Why?
|
Administration, Cutaneous | 5 | 2000 | 711 | 0.120 |
Why?
|
Quality Control | 2 | 2015 | 841 | 0.120 |
Why?
|
Osteoporosis | 2 | 2001 | 1580 | 0.120 |
Why?
|
Climacteric | 1 | 1994 | 57 | 0.120 |
Why?
|
Models, Genetic | 3 | 2001 | 3494 | 0.120 |
Why?
|
Chromosome Aberrations | 1 | 2021 | 1813 | 0.120 |
Why?
|
Ovulation | 2 | 2009 | 189 | 0.120 |
Why?
|
Pre-Eclampsia | 1 | 2023 | 1200 | 0.120 |
Why?
|
Religion | 1 | 2017 | 356 | 0.120 |
Why?
|
Physician-Patient Relations | 2 | 2014 | 3229 | 0.120 |
Why?
|
Gestational Age | 2 | 2020 | 3493 | 0.120 |
Why?
|
Severity of Illness Index | 4 | 2019 | 15540 | 0.120 |
Why?
|
Gene Frequency | 1 | 2001 | 3588 | 0.120 |
Why?
|
Drug Administration Schedule | 3 | 2018 | 4933 | 0.120 |
Why?
|
Skinfold Thickness | 1 | 2014 | 162 | 0.120 |
Why?
|
Diabetes, Gestational | 1 | 2023 | 1184 | 0.120 |
Why?
|
Family Characteristics | 1 | 2019 | 1000 | 0.120 |
Why?
|
Sex Factors | 2 | 2019 | 10397 | 0.120 |
Why?
|
Health Benefit Plans, Employee | 1 | 2016 | 332 | 0.120 |
Why?
|
Luteal Cells | 1 | 2013 | 19 | 0.110 |
Why?
|
Pregnancy Complications | 2 | 2018 | 2861 | 0.110 |
Why?
|
Cannabis | 1 | 2020 | 439 | 0.110 |
Why?
|
Lipoproteins | 1 | 1998 | 878 | 0.110 |
Why?
|
Aged | 13 | 2019 | 163280 | 0.110 |
Why?
|
Living Donors | 1 | 2017 | 620 | 0.110 |
Why?
|
Birth Weight | 2 | 2023 | 2069 | 0.110 |
Why?
|
Leiomyoma | 2 | 2001 | 730 | 0.110 |
Why?
|
Hematoma | 1 | 2018 | 758 | 0.110 |
Why?
|
Time Factors | 8 | 2019 | 40075 | 0.110 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2010 | 11524 | 0.110 |
Why?
|
Body Weight | 2 | 2006 | 4669 | 0.110 |
Why?
|
Comparative Genomic Hybridization | 1 | 2014 | 496 | 0.110 |
Why?
|
Injections, Subcutaneous | 1 | 2014 | 666 | 0.110 |
Why?
|
Morula | 1 | 2012 | 11 | 0.110 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2017 | 10943 | 0.100 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2023 | 1736 | 0.100 |
Why?
|
Prognosis | 5 | 2020 | 29063 | 0.100 |
Why?
|
Achievement | 1 | 2013 | 291 | 0.100 |
Why?
|
Body Height | 1 | 1998 | 1577 | 0.100 |
Why?
|
Ovariectomy | 4 | 2007 | 661 | 0.100 |
Why?
|
Statistics, Nonparametric | 4 | 2011 | 2886 | 0.100 |
Why?
|
Health Literacy | 1 | 2017 | 414 | 0.100 |
Why?
|
Granulosa Cells | 1 | 2012 | 120 | 0.100 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2005 | 2988 | 0.100 |
Why?
|
Gynecologic Surgical Procedures | 2 | 2015 | 336 | 0.100 |
Why?
|
Prospective Studies | 11 | 2022 | 53288 | 0.100 |
Why?
|
Stillbirth | 1 | 2014 | 346 | 0.100 |
Why?
|
Premature Birth | 1 | 2023 | 1721 | 0.100 |
Why?
|
Overweight | 2 | 2020 | 2371 | 0.100 |
Why?
|
Emergencies | 1 | 2017 | 1170 | 0.100 |
Why?
|
Probability | 1 | 2016 | 2505 | 0.100 |
Why?
|
Maternal Nutritional Physiological Phenomena | 1 | 2014 | 378 | 0.100 |
Why?
|
Tissue and Organ Harvesting | 2 | 2004 | 369 | 0.090 |
Why?
|
Abdominal Cavity | 1 | 2011 | 52 | 0.090 |
Why?
|
Weight Loss | 2 | 2019 | 2622 | 0.090 |
Why?
|
Patient Rights | 1 | 2011 | 126 | 0.090 |
Why?
|
Boston | 4 | 2011 | 9313 | 0.090 |
Why?
|
Inservice Training | 1 | 2013 | 392 | 0.090 |
Why?
|
Robotics | 1 | 2018 | 899 | 0.090 |
Why?
|
Neoadjuvant Therapy | 1 | 2021 | 2728 | 0.090 |
Why?
|
Medical Records | 2 | 2009 | 1413 | 0.090 |
Why?
|
Statistics as Topic | 1 | 2016 | 2373 | 0.090 |
Why?
|
Vagina | 2 | 2011 | 825 | 0.090 |
Why?
|
Registries | 3 | 2022 | 8089 | 0.090 |
Why?
|
Germ-Line Mutation | 1 | 2017 | 1788 | 0.090 |
Why?
|
Health Care Surveys | 1 | 2017 | 2453 | 0.090 |
Why?
|
Child | 6 | 2023 | 77709 | 0.090 |
Why?
|
Anxiety | 3 | 2023 | 4297 | 0.090 |
Why?
|
Incidence | 4 | 2020 | 20947 | 0.090 |
Why?
|
Decision Making | 2 | 2014 | 3887 | 0.090 |
Why?
|
Uterine Neoplasms | 2 | 2001 | 1513 | 0.090 |
Why?
|
Heart Rate, Fetal | 1 | 2009 | 75 | 0.080 |
Why?
|
Treatment Failure | 2 | 2011 | 2618 | 0.080 |
Why?
|
Homeodomain Proteins | 2 | 2009 | 2421 | 0.080 |
Why?
|
Multivariate Analysis | 3 | 2013 | 12245 | 0.080 |
Why?
|
Inhibins | 1 | 2009 | 211 | 0.080 |
Why?
|
Parity | 1 | 2012 | 929 | 0.080 |
Why?
|
Cell Count | 2 | 2010 | 1856 | 0.080 |
Why?
|
Sex Ratio | 1 | 2008 | 110 | 0.080 |
Why?
|
Population Surveillance | 1 | 2019 | 2616 | 0.080 |
Why?
|
Cell Division | 5 | 2006 | 4568 | 0.080 |
Why?
|
Biopsy | 3 | 2017 | 6756 | 0.080 |
Why?
|
Bone Density | 1 | 2001 | 3468 | 0.080 |
Why?
|
Cost-Benefit Analysis | 1 | 2021 | 5391 | 0.080 |
Why?
|
Risk Assessment | 3 | 2019 | 23338 | 0.080 |
Why?
|
Feasibility Studies | 1 | 2018 | 5078 | 0.080 |
Why?
|
Analysis of Variance | 3 | 2005 | 6365 | 0.080 |
Why?
|
Organ Transplantation | 1 | 2018 | 1139 | 0.080 |
Why?
|
Receptors, Progesterone | 4 | 2012 | 1097 | 0.080 |
Why?
|
Cervix Uteri | 3 | 2004 | 590 | 0.080 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2014 | 2649 | 0.080 |
Why?
|
Folic Acid | 1 | 2014 | 1300 | 0.080 |
Why?
|
Fetal Heart | 1 | 2009 | 276 | 0.070 |
Why?
|
Regression Analysis | 2 | 2009 | 6459 | 0.070 |
Why?
|
Transplantation Conditioning | 2 | 2021 | 1598 | 0.070 |
Why?
|
Patient Compliance | 1 | 2017 | 2684 | 0.070 |
Why?
|
Mammary Glands, Human | 1 | 2008 | 199 | 0.070 |
Why?
|
Infertility, Male | 1 | 2010 | 409 | 0.070 |
Why?
|
Family | 1 | 2017 | 3147 | 0.070 |
Why?
|
Case-Control Studies | 8 | 2020 | 21746 | 0.070 |
Why?
|
Data Interpretation, Statistical | 1 | 2016 | 2716 | 0.070 |
Why?
|
Epidermal Growth Factor | 1 | 2009 | 708 | 0.070 |
Why?
|
Health Policy | 1 | 2018 | 2661 | 0.070 |
Why?
|
Gonadal Steroid Hormones | 2 | 2020 | 712 | 0.070 |
Why?
|
Educational Measurement | 1 | 2013 | 1210 | 0.070 |
Why?
|
Fetus | 1 | 2013 | 1880 | 0.070 |
Why?
|
Half-Life | 2 | 1998 | 661 | 0.070 |
Why?
|
Gonadotropins, Pituitary | 1 | 2005 | 73 | 0.070 |
Why?
|
Pedigree | 4 | 2001 | 4644 | 0.060 |
Why?
|
Protein Isoforms | 1 | 2010 | 1730 | 0.060 |
Why?
|
Socioeconomic Factors | 2 | 2016 | 7785 | 0.060 |
Why?
|
HIV Infections | 1 | 2011 | 16718 | 0.060 |
Why?
|
Glioma | 1 | 2020 | 3401 | 0.060 |
Why?
|
Child of Impaired Parents | 1 | 2008 | 455 | 0.060 |
Why?
|
Child, Preschool | 3 | 2023 | 41006 | 0.060 |
Why?
|
Pilot Projects | 2 | 2017 | 8324 | 0.060 |
Why?
|
Internet | 1 | 2017 | 3064 | 0.060 |
Why?
|
Radiotherapy | 1 | 2011 | 1533 | 0.060 |
Why?
|
Proportional Hazards Models | 1 | 2019 | 12354 | 0.060 |
Why?
|
Fellowships and Scholarships | 1 | 2013 | 1076 | 0.060 |
Why?
|
Bone and Bones | 2 | 2013 | 2575 | 0.060 |
Why?
|
Animals | 13 | 2023 | 168757 | 0.060 |
Why?
|
Polymerase Chain Reaction | 5 | 2012 | 6171 | 0.060 |
Why?
|
Depression | 3 | 2023 | 7766 | 0.060 |
Why?
|
Morphogenesis | 1 | 2007 | 752 | 0.060 |
Why?
|
Infant | 2 | 2023 | 35136 | 0.060 |
Why?
|
Aged, 80 and over | 5 | 2017 | 57776 | 0.050 |
Why?
|
Health Care Costs | 1 | 2016 | 3209 | 0.050 |
Why?
|
Acupuncture Therapy | 1 | 2007 | 464 | 0.050 |
Why?
|
Stress, Psychological | 1 | 2018 | 4245 | 0.050 |
Why?
|
Ultrasonography | 5 | 2013 | 5985 | 0.050 |
Why?
|
Laparoscopy | 3 | 2011 | 2151 | 0.050 |
Why?
|
Sperm Motility | 1 | 2023 | 253 | 0.050 |
Why?
|
Paclitaxel | 1 | 2010 | 1708 | 0.050 |
Why?
|
Aging | 2 | 2017 | 8664 | 0.050 |
Why?
|
Tissue Adhesions | 1 | 2023 | 235 | 0.050 |
Why?
|
Receptors, Prolactin | 1 | 2001 | 17 | 0.050 |
Why?
|
Attitude to Health | 1 | 2011 | 2052 | 0.050 |
Why?
|
Glomerulonephritis | 1 | 2004 | 372 | 0.050 |
Why?
|
Data Collection | 1 | 2011 | 3341 | 0.050 |
Why?
|
Croatia | 1 | 2001 | 35 | 0.050 |
Why?
|
Trust | 1 | 2006 | 505 | 0.050 |
Why?
|
Diethylstilbestrol | 1 | 2001 | 93 | 0.050 |
Why?
|
Emergency Medical Services | 1 | 2013 | 1917 | 0.050 |
Why?
|
Russia | 2 | 1999 | 408 | 0.050 |
Why?
|
Mullerian Ducts | 1 | 2001 | 198 | 0.050 |
Why?
|
Testis | 1 | 2004 | 803 | 0.050 |
Why?
|
Endometrium | 3 | 2017 | 424 | 0.050 |
Why?
|
Diploidy | 1 | 2000 | 138 | 0.050 |
Why?
|
Embryonic Stem Cells | 1 | 2008 | 1294 | 0.050 |
Why?
|
Cell Culture Techniques | 1 | 2008 | 1678 | 0.050 |
Why?
|
Th1 Cells | 1 | 2005 | 1057 | 0.050 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2019 | 15519 | 0.040 |
Why?
|
Pregnancy, High-Risk | 1 | 2000 | 120 | 0.040 |
Why?
|
Twins, Monozygotic | 1 | 2001 | 458 | 0.040 |
Why?
|
Neovascularization, Pathologic | 1 | 2010 | 2635 | 0.040 |
Why?
|
Sperm Count | 1 | 2020 | 216 | 0.040 |
Why?
|
Sex Hormone-Binding Globulin | 2 | 2005 | 548 | 0.040 |
Why?
|
Carrier Proteins | 1 | 2012 | 5021 | 0.040 |
Why?
|
Culture Media | 1 | 2021 | 908 | 0.040 |
Why?
|
Kyrgyzstan | 1 | 1998 | 3 | 0.040 |
Why?
|
Immunity, Cellular | 1 | 2005 | 1607 | 0.040 |
Why?
|
Blastomeres | 1 | 1998 | 28 | 0.040 |
Why?
|
Anesthesia, Intravenous | 1 | 2019 | 130 | 0.040 |
Why?
|
Semen Analysis | 1 | 2020 | 204 | 0.040 |
Why?
|
Cyclophosphamide | 1 | 2004 | 2242 | 0.040 |
Why?
|
Cicatrix | 1 | 2004 | 764 | 0.040 |
Why?
|
Membrane Glycoproteins | 1 | 2009 | 3768 | 0.040 |
Why?
|
Lactation Disorders | 1 | 2017 | 16 | 0.040 |
Why?
|
Parthenogenesis | 1 | 2017 | 31 | 0.040 |
Why?
|
BRCA2 Protein | 1 | 2022 | 794 | 0.040 |
Why?
|
Predictive Value of Tests | 4 | 2012 | 15076 | 0.040 |
Why?
|
Cannabinoids | 1 | 2020 | 166 | 0.040 |
Why?
|
Adenocarcinoma | 1 | 1995 | 6364 | 0.040 |
Why?
|
Clinical Competence | 1 | 2013 | 4687 | 0.040 |
Why?
|
Antibodies, Monoclonal | 2 | 2010 | 9274 | 0.040 |
Why?
|
Genital Diseases, Female | 1 | 1998 | 197 | 0.040 |
Why?
|
Cytokines | 2 | 2018 | 7322 | 0.040 |
Why?
|
Absorption | 1 | 1996 | 248 | 0.040 |
Why?
|
Abortifacient Agents, Nonsteroidal | 1 | 2017 | 62 | 0.040 |
Why?
|
Anesthesia, General | 1 | 2004 | 1171 | 0.040 |
Why?
|
Neoplasm Proteins | 1 | 2009 | 3703 | 0.040 |
Why?
|
Time-Lapse Imaging | 1 | 2017 | 195 | 0.030 |
Why?
|
Estrogens, Conjugated (USP) | 1 | 1998 | 275 | 0.030 |
Why?
|
False Negative Reactions | 1 | 2017 | 588 | 0.030 |
Why?
|
Intraoperative Complications | 2 | 2000 | 1198 | 0.030 |
Why?
|
Pregnancy, Animal | 1 | 1996 | 134 | 0.030 |
Why?
|
Mexico | 1 | 1998 | 690 | 0.030 |
Why?
|
Fentanyl | 1 | 2019 | 410 | 0.030 |
Why?
|
Medroxyprogesterone Acetate | 1 | 1996 | 162 | 0.030 |
Why?
|
Heterozygote | 1 | 2022 | 2804 | 0.030 |
Why?
|
Suction | 1 | 2017 | 267 | 0.030 |
Why?
|
Genetic Heterogeneity | 1 | 1999 | 733 | 0.030 |
Why?
|
Israel | 1 | 1998 | 796 | 0.030 |
Why?
|
Anesthetics, Intravenous | 1 | 2019 | 417 | 0.030 |
Why?
|
Fetal Death | 1 | 2017 | 448 | 0.030 |
Why?
|
Gene Expression | 3 | 2000 | 7799 | 0.030 |
Why?
|
Costs and Cost Analysis | 1 | 2021 | 1681 | 0.030 |
Why?
|
Evidence-Based Medicine | 1 | 2007 | 3610 | 0.030 |
Why?
|
Ergotamines | 1 | 1994 | 4 | 0.030 |
Why?
|
Belladonna Alkaloids | 1 | 1994 | 4 | 0.030 |
Why?
|
Methysergide | 1 | 1994 | 28 | 0.030 |
Why?
|
Genetic Variation | 2 | 2019 | 6544 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2011 | 9959 | 0.030 |
Why?
|
Comorbidity | 1 | 2009 | 10388 | 0.030 |
Why?
|
Reoperation | 1 | 2004 | 4201 | 0.030 |
Why?
|
Transcription, Genetic | 2 | 2001 | 7722 | 0.030 |
Why?
|
Neoplasm Staging | 1 | 2009 | 11031 | 0.030 |
Why?
|
Panax | 1 | 1994 | 29 | 0.030 |
Why?
|
Catheterization | 1 | 2000 | 1470 | 0.030 |
Why?
|
Age of Onset | 1 | 2001 | 3271 | 0.030 |
Why?
|
Double-Blind Method | 3 | 2000 | 12026 | 0.030 |
Why?
|
Colorado | 1 | 2014 | 163 | 0.030 |
Why?
|
Culture Media, Conditioned | 1 | 1995 | 537 | 0.030 |
Why?
|
Delivery, Obstetric | 1 | 2001 | 906 | 0.030 |
Why?
|
Plants, Medicinal | 1 | 1994 | 167 | 0.030 |
Why?
|
Multifactorial Inheritance | 1 | 2001 | 1194 | 0.030 |
Why?
|
Sexual Partners | 1 | 2018 | 730 | 0.030 |
Why?
|
Phenobarbital | 1 | 1994 | 193 | 0.030 |
Why?
|
Serum Albumin | 1 | 1996 | 676 | 0.030 |
Why?
|
Genotype | 3 | 2008 | 12951 | 0.030 |
Why?
|
Adrenergic alpha-Agonists | 1 | 1994 | 177 | 0.030 |
Why?
|
Directive Counseling | 1 | 2015 | 166 | 0.030 |
Why?
|
Cadaver | 1 | 2017 | 1337 | 0.030 |
Why?
|
Mice, Inbred BALB C | 4 | 2007 | 6386 | 0.030 |
Why?
|
Hypertension, Pulmonary | 1 | 2004 | 1537 | 0.030 |
Why?
|
Cell Survival | 2 | 2017 | 5882 | 0.030 |
Why?
|
Genetics, Population | 1 | 1998 | 934 | 0.030 |
Why?
|
Gene Expression Regulation | 2 | 2008 | 12072 | 0.030 |
Why?
|
RNA | 2 | 2017 | 2749 | 0.030 |
Why?
|
Smoking | 2 | 2012 | 8987 | 0.030 |
Why?
|
Combined Modality Therapy | 2 | 2020 | 8642 | 0.030 |
Why?
|
Receptors, LH | 1 | 2012 | 19 | 0.030 |
Why?
|
Twins | 1 | 1994 | 339 | 0.030 |
Why?
|
Propofol | 1 | 2019 | 629 | 0.030 |
Why?
|
Recurrence | 1 | 2004 | 8340 | 0.030 |
Why?
|
Early Diagnosis | 1 | 2017 | 1184 | 0.030 |
Why?
|
Receptors, Prostaglandin E, EP3 Subtype | 1 | 2012 | 23 | 0.030 |
Why?
|
Telomerase | 1 | 2017 | 730 | 0.030 |
Why?
|
Tissue Banks | 1 | 2013 | 184 | 0.030 |
Why?
|
Follow-Up Studies | 4 | 2020 | 39050 | 0.030 |
Why?
|
Cholesterol, HDL | 1 | 1998 | 1814 | 0.030 |
Why?
|
Clone Cells | 1 | 1995 | 1692 | 0.030 |
Why?
|
Women's Health | 2 | 2014 | 2034 | 0.020 |
Why?
|
Genes, BRCA2 | 1 | 2015 | 618 | 0.020 |
Why?
|
Antidepressive Agents | 1 | 2023 | 2838 | 0.020 |
Why?
|
Mice | 8 | 2023 | 81183 | 0.020 |
Why?
|
Quantitative Trait Loci | 1 | 2019 | 2019 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2007 | 7913 | 0.020 |
Why?
|
Injections | 1 | 1994 | 840 | 0.020 |
Why?
|
Blood Pressure | 2 | 1999 | 8554 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2004 | 4149 | 0.020 |
Why?
|
Cricetulus | 1 | 2012 | 816 | 0.020 |
Why?
|
Genes, BRCA1 | 1 | 2015 | 781 | 0.020 |
Why?
|
Sexual Behavior | 1 | 2000 | 2057 | 0.020 |
Why?
|
Placebos | 1 | 1995 | 1676 | 0.020 |
Why?
|
Fragile X Mental Retardation Protein | 1 | 2011 | 117 | 0.020 |
Why?
|
Ultrasonography, Interventional | 1 | 2019 | 1486 | 0.020 |
Why?
|
Sex Characteristics | 1 | 2001 | 2585 | 0.020 |
Why?
|
Diagnosis, Differential | 2 | 2017 | 12959 | 0.020 |
Why?
|
Immunoprecipitation | 1 | 2012 | 905 | 0.020 |
Why?
|
RNA, Messenger | 4 | 2001 | 13033 | 0.020 |
Why?
|
Random Allocation | 1 | 1995 | 2429 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 2 | 2022 | 17446 | 0.020 |
Why?
|
CHO Cells | 1 | 2012 | 1406 | 0.020 |
Why?
|
Fragile X Syndrome | 1 | 2011 | 115 | 0.020 |
Why?
|
DNA-Binding Proteins | 1 | 2007 | 9648 | 0.020 |
Why?
|
Glycosylation | 1 | 2012 | 1126 | 0.020 |
Why?
|
Renal Dialysis | 1 | 1998 | 1786 | 0.020 |
Why?
|
Repetitive Sequences, Nucleic Acid | 1 | 2011 | 798 | 0.020 |
Why?
|
Research Design | 2 | 2020 | 5987 | 0.020 |
Why?
|
HCT116 Cells | 1 | 2010 | 408 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2018 | 1889 | 0.020 |
Why?
|
Menarche | 1 | 2012 | 516 | 0.020 |
Why?
|
Cricetinae | 1 | 2012 | 2472 | 0.020 |
Why?
|
Postoperative Complications | 3 | 2019 | 15295 | 0.020 |
Why?
|
Siblings | 1 | 2013 | 854 | 0.020 |
Why?
|
Microarray Analysis | 1 | 2012 | 767 | 0.020 |
Why?
|
Drug Combinations | 1 | 1994 | 1959 | 0.020 |
Why?
|
Cell Size | 1 | 2010 | 643 | 0.020 |
Why?
|
Milk, Human | 1 | 2012 | 490 | 0.020 |
Why?
|
Risk Reduction Behavior | 1 | 2015 | 1125 | 0.020 |
Why?
|
Motivation | 1 | 2017 | 1971 | 0.020 |
Why?
|
Organ Culture Techniques | 2 | 2000 | 813 | 0.020 |
Why?
|
DNA Damage | 1 | 2017 | 2432 | 0.020 |
Why?
|
Abortion, Induced | 1 | 2013 | 458 | 0.020 |
Why?
|
Kinetics | 1 | 1995 | 6473 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 1995 | 6314 | 0.020 |
Why?
|
Anthropometry | 1 | 2012 | 1350 | 0.020 |
Why?
|
Electroacupuncture | 1 | 2007 | 60 | 0.020 |
Why?
|
Androgens | 1 | 1994 | 1281 | 0.020 |
Why?
|
src-Family Kinases | 1 | 2009 | 551 | 0.020 |
Why?
|
Membrane Transport Proteins | 1 | 2012 | 1028 | 0.020 |
Why?
|
Mesoderm | 1 | 2009 | 686 | 0.020 |
Why?
|
Ambulatory Care | 1 | 2017 | 2708 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2010 | 2085 | 0.020 |
Why?
|
Cell Proliferation | 2 | 2012 | 10481 | 0.020 |
Why?
|
Blotting, Western | 1 | 2012 | 5179 | 0.020 |
Why?
|
Peer Review | 1 | 2007 | 209 | 0.020 |
Why?
|
Cell Line, Tumor | 2 | 2012 | 16689 | 0.020 |
Why?
|
Review Literature as Topic | 1 | 2007 | 336 | 0.020 |
Why?
|
DNA Primers | 1 | 2009 | 2892 | 0.020 |
Why?
|
In Situ Hybridization | 2 | 2000 | 1950 | 0.020 |
Why?
|
Patient Education as Topic | 1 | 2015 | 2278 | 0.020 |
Why?
|
Cell Cycle | 1 | 2012 | 2967 | 0.020 |
Why?
|
Stromal Cells | 2 | 2001 | 1355 | 0.010 |
Why?
|
Epithelial Cells | 2 | 2009 | 3690 | 0.010 |
Why?
|
Ovum | 1 | 2004 | 189 | 0.010 |
Why?
|
Infusion Pumps | 1 | 2004 | 163 | 0.010 |
Why?
|
Mice, Nude | 1 | 2010 | 3689 | 0.010 |
Why?
|
Epoprostenol | 1 | 2004 | 254 | 0.010 |
Why?
|
Health Surveys | 1 | 2013 | 4037 | 0.010 |
Why?
|
Cells, Cultured | 2 | 2010 | 19229 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2018 | 14722 | 0.010 |
Why?
|
Self Report | 1 | 2013 | 3558 | 0.010 |
Why?
|
Meta-Analysis as Topic | 1 | 2007 | 1344 | 0.010 |
Why?
|
Fetal Growth Retardation | 1 | 2006 | 570 | 0.010 |
Why?
|
Cell Transplantation | 1 | 2004 | 477 | 0.010 |
Why?
|
Models, Statistical | 1 | 2016 | 5102 | 0.010 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2009 | 1101 | 0.010 |
Why?
|
Dietary Supplements | 1 | 2014 | 3297 | 0.010 |
Why?
|
Calcium | 1 | 1995 | 5756 | 0.010 |
Why?
|
Infant, Low Birth Weight | 1 | 2006 | 850 | 0.010 |
Why?
|
Academic Medical Centers | 1 | 2011 | 2759 | 0.010 |
Why?
|
Neoplasm Invasiveness | 1 | 2009 | 3616 | 0.010 |
Why?
|
Transfection | 1 | 2009 | 5892 | 0.010 |
Why?
|
Massachusetts | 1 | 2014 | 8663 | 0.010 |
Why?
|
Biomedical Research | 1 | 2016 | 3309 | 0.010 |
Why?
|
Gels | 1 | 2001 | 427 | 0.010 |
Why?
|
Clomiphene | 1 | 2000 | 72 | 0.010 |
Why?
|
Protein Binding | 1 | 2012 | 9386 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2019 | 12261 | 0.010 |
Why?
|
Life Style | 1 | 2012 | 3835 | 0.010 |
Why?
|
Turkmenistan | 1 | 1999 | 3 | 0.010 |
Why?
|
Angiogenesis Inhibitors | 1 | 2010 | 2038 | 0.010 |
Why?
|
Up-Regulation | 1 | 2009 | 4217 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2009 | 3505 | 0.010 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2009 | 2455 | 0.010 |
Why?
|
Computational Biology | 1 | 2012 | 3521 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2017 | 21827 | 0.010 |
Why?
|
Hypertension | 1 | 1999 | 8480 | 0.010 |
Why?
|
Survival Rate | 1 | 2013 | 12788 | 0.010 |
Why?
|
Age Distribution | 1 | 2005 | 2902 | 0.010 |
Why?
|
Radioimmunoassay | 1 | 1999 | 919 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 2 | 2017 | 35421 | 0.010 |
Why?
|
Mutation | 1 | 2022 | 29786 | 0.010 |
Why?
|
Fibroblasts | 1 | 2008 | 4161 | 0.010 |
Why?
|
Base Sequence | 1 | 2009 | 12797 | 0.010 |
Why?
|
Exercise | 1 | 1994 | 5615 | 0.010 |
Why?
|
Quantitative Trait, Heritable | 1 | 2000 | 544 | 0.010 |
Why?
|
Drug Synergism | 1 | 2001 | 1792 | 0.010 |
Why?
|
Cell Differentiation | 2 | 2008 | 11483 | 0.010 |
Why?
|
Constriction, Pathologic | 1 | 2000 | 1107 | 0.010 |
Why?
|
RNA-Directed DNA Polymerase | 1 | 1996 | 248 | 0.010 |
Why?
|
Laparotomy | 1 | 1998 | 473 | 0.010 |
Why?
|
Diet | 1 | 2014 | 7939 | 0.010 |
Why?
|
Likelihood Functions | 1 | 1999 | 1005 | 0.010 |
Why?
|
Epithelium | 1 | 2000 | 1679 | 0.010 |
Why?
|
Signal Transduction | 2 | 2009 | 23403 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2012 | 7880 | 0.010 |
Why?
|
Cell Line | 1 | 2009 | 15997 | 0.010 |
Why?
|
Antihypertensive Agents | 1 | 2004 | 2046 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2017 | 20129 | 0.010 |
Why?
|
Prevalence | 1 | 2011 | 15226 | 0.010 |
Why?
|
Proteins | 1 | 2008 | 6103 | 0.010 |
Why?
|
Cardiovascular Diseases | 1 | 1998 | 15165 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2008 | 9438 | 0.010 |
Why?
|
Phenotype | 1 | 2008 | 16365 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2000 | 6489 | 0.010 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2001 | 3617 | 0.010 |
Why?
|
Adipose Tissue | 1 | 2001 | 3279 | 0.010 |
Why?
|
Reference Values | 1 | 1995 | 4982 | 0.000 |
Why?
|
Mental Health | 1 | 2000 | 3019 | 0.000 |
Why?
|
Quality of Life | 1 | 2007 | 12804 | 0.000 |
Why?
|
Rats, Sprague-Dawley | 1 | 1996 | 8301 | 0.000 |
Why?
|
DNA | 1 | 1999 | 7301 | 0.000 |
Why?
|
Thyroid (USP) | 1 | 1962 | 3 | 0.000 |
Why?
|
Rats | 1 | 1996 | 24260 | 0.000 |
Why?
|
Thyroid Hormones | 1 | 1962 | 390 | 0.000 |
Why?
|
Hospitalization | 1 | 1998 | 10262 | 0.000 |
Why?
|
Thyroid Gland | 1 | 1962 | 1173 | 0.000 |
Why?
|